Literature DB >> 16763159

Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants.

Kathy L E Klos1, Charles F Sing, Eric Boerwinkle, Sara C Hamon, Thomas J Rea, Andrew Clark, Myriam Fornage, James E Hixson.   

Abstract

OBJECTIVE: To identify common variations in genes in the reverse cholesterol transport pathway with nongender-specific influence on plasma lipid and apolipoprotein levels. METHODS AND
RESULTS: An average of 5 single nucleotide polymorphisms (SNPs) were genotyped within each of 45 genomic regions (54 genes) in blacks (1131 females and 812 males) and whites (1102 females and 954 males) from the Coronary Artery Risk Development in Young Adults (CARDIA) study. SNPs and gene-based 3-SNP haplotypes were evaluated for their ability to predict variation in plasma apolipoproteins (apo) A-I and apoB, total cholesterol (TC), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides (TG). We identified 14 SNPs in 6 candidate gene regions that explained statistically significant variation in the same trait in both genders of at least one race and with evidence of consistent genotype mean trend across gender within race. Haplotype analyses identified 9 candidate gene regions that explained statistically significant variation in one or both races.
CONCLUSIONS: Four gene regions, ABCA1, APOA1/C3/A4/A5, APOE/C1/C4/C2, and CETP, explained plasma lipoprotein variation most consistently across strata. Other gene regions that influence plasma lipid and apolipoprotein levels within race include CYP7A1, LPL, PPARA, SOAT1, and SREBF2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763159     DOI: 10.1161/01.ATV.0000231523.19199.45

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

2.  A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort.

Authors:  Danielle M Greenawalt; Radu Dobrin; Eugene Chudin; Ida J Hatoum; Christine Suver; John Beaulaurier; Bin Zhang; Victor Castro; Jun Zhu; Solveig K Sieberts; Susanna Wang; Cliona Molony; Steven B Heymsfield; Daniel M Kemp; Marc L Reitman; Pek Yee Lum; Eric E Schadt; Lee M Kaplan
Journal:  Genome Res       Date:  2011-05-20       Impact factor: 9.043

3.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

4.  WWOX gene is associated with HDL cholesterol and triglyceride levels.

Authors:  María E Sáez; Antonio González-Pérez; María T Martínez-Larrad; Javier Gayán; Luis M Real; Manuel Serrano-Ríos; Agustín Ruiz
Journal:  BMC Med Genet       Date:  2010-10-14       Impact factor: 2.103

Review 5.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

6.  Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study.

Authors:  Amanda K Golembesky; Marilie D Gammon; Kari E North; Jeannette T Bensen; Jane C Schroeder; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Carcinogenesis       Date:  2008-06-26       Impact factor: 4.944

7.  Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Erik Biros; Matthew Cooper; Nicole Warrington; Lyle J Palmer; Paul E Norman
Journal:  Atherosclerosis       Date:  2009-09-25       Impact factor: 5.162

8.  APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels.

Authors:  Kathy Klos; Lawrence Shimmin; Christie Ballantyne; Eric Boerwinkle; Andrew Clark; Josef Coresh; Craig Hanis; Kiang Liu; Scott Sayre; James Hixson
Journal:  Hum Mol Genet       Date:  2008-03-31       Impact factor: 6.150

9.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.

Authors:  Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

10.  Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Chao-Qiang Lai
Journal:  Lipids Health Dis       Date:  2011-08-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.